Quent Capital, LLC Biomarin Pharmaceutical Inc Transaction History
Quent Capital, LLC
- $931 Million
- Q4 2024
A detailed history of Quent Capital, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Quent Capital, LLC holds 156 shares of BMRN stock, worth $10,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156
Previous 256
39.06%
Holding current value
$10,765
Previous $17,000
41.18%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.57 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.34 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.26 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.02 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$897 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...